Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Zhanna Shubin"'
Autor:
Thembi Mdluli, Bonnie M. Slike, Daniel J. Curtis, Zhanna Shubin, Ursula Tran, Yifan Li, Vincent Dussupt, Letzibeth Mendez-Rivera, Suteeraporn Pinyakorn, Daniel J. Stieh, Frank L. Tomaka, Hanneke Schuitemaker, Maria G. Pau, Donn J. Colby, Eugène Kroon, Carlo Sacdalan, Mark de Souza, Nittaya Phanupak, Denise C. Hsu, Jintanat Ananworanich, Julie A. Ake, Lydie Trautmann, Sandhya Vasan, Merlin L. Robb, Shelly J. Krebs, Dominic Paquin-Proulx, Morgane Rolland
Publikováno v:
Cell Reports, Vol 43, Iss 6, Pp 114344- (2024)
Summary: A heterologous Ad26/MVA vaccine was given prior to an analytic treatment interruption (ATI) in people living with HIV-1 (mainly CRF01_AE) who initiated antiretroviral treatment (ART) during acute HIV-1. We investigate the impact of Ad26/MVA
Externí odkaz:
https://doaj.org/article/2a53194be3584d4cb1d89d2981acfbb5
Autor:
Margaret C. Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, Siriwat Akapirat, Zhanna Shubin, Dohoon Kim, Lindsay Wieczorek, Victoria R. Polonis, Hung V. Trinh, Mangala Rao, Hanna Anenia, Michael D. Barrera, Jacob Boeckelman, Barbara Nails, Pallavi Thapa, Michelle Zemil, Carlo Sacdalan, Eugene Kroon, Boot Kaewboon, Somporn Tipsuk, Surat Jongrakthaitae, Sanjay Gurunathan, Faruk Sinangil, Jerome H. Kim, Merlin L. Robb, Julie A. Ake, Robert J. O’Connell, Punnee Pitisutthithum, Sorachai Nitayaphan, Suwat Chariyalertsak, Michael A. Eller, Nittaya Phanuphak, Sandhya Vasan, the RV, RV328 study groups
Publikováno v:
JCI Insight, Vol 8, Iss 9 (2023)
The RV144 phase III vaccine trial demonstrated that ALVAC-HIV and AIDSVAX B/E administration over 6 months resulted in 31% efficacy in preventing HIV acquisition, while administration of AIDSVAX B/E alone in both VAX003 and VAX004 studies failed to s
Externí odkaz:
https://doaj.org/article/54ea0fbbfd224eb79d9efe0dfded1c6a
Autor:
Brittani M. Barrows, Shelly J. Krebs, Ningbo Jian, Michelle Zemil, Bonnie M. Slike, Vincent Dussupt, Ursula Tran, Letzibeth Mendez-Rivera, David Chang, Anne Marie O’Sullivan, Brendan Mann, Eric Sanders-Buell, Zhanna Shubin, Matt Creegan, Dominic Paquin-Proulx, Philip Ehrenberg, Agnes Laurence-Chenine, Kriengkrai Srithanaviboonchai, Rasmi Thomas, Michael A. Eller, Guido Ferrari, Merlin Robb, Venigalla Rao, Sodsai Tovanabutra, Victoria R. Polonis, Lindsay Wieczorek
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionInfants acquire maternal antibodies by Fc receptor transcytosis across the placenta during pregnancy. Fc receptors are expressed on immune cells and are important for activation of effector cell functions.MethodsIn this study, we evaluate
Externí odkaz:
https://doaj.org/article/cf38bdf7a92d429dbb06fe53fdb887b3
Autor:
Isabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, Jason Gorman, Massimiliano Bissa, Mohammad A. Rahman, Anush Arakelyan, Irene Kalisz, Stephen Whitney, Manuel Becerra-Flores, Eric Ni, Kristina Peachman, Hung V. Trinh, Michael Read, Mei-Hue Liu, Donald Van Ryk, Dominic Paquin-Proulx, Zhanna Shubin, Marina Tuyishime, Jennifer Peele, Mohammed S. Ahmadi, Raffaello Verardi, Juliane Hill, Margaret Beddall, Richard Nguyen, James D. Stamos, Dai Fujikawa, Susie Min, Luca Schifanella, Monica Vaccari, Veronica Galli, Melvin N. Doster, Namal P.M. Liyanage, Sarkis Sarkis, Francesca Caccuri, Celia LaBranche, David C. Montefiori, Georgia D. Tomaras, Xiaoying Shen, Margherita Rosati, Barbara K. Felber, George N. Pavlakis, David J. Venzon, William Magnanelli, Matthew Breed, Josh Kramer, Brandon F. Keele, Michael A. Eller, Claudia Cicala, James Arthos, Guido Ferrari, Leonid Margolis, Marjorie Robert-Guroff, Peter D. Kwong, Mario Roederer, Mangala Rao, Timothy J. Cardozo, Genoveffa Franchini
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102047- (2021)
Summary: The efficacy of ALVAC-based HIV and SIV vaccines in humans and macaques correlates with antibodies to envelope variable region 2 (V2). We show here that vaccine-induced antibodies to SIV variable region 1 (V1) inhibit anti-V2 antibody-mediat
Externí odkaz:
https://doaj.org/article/0f4c13b40f5b4bb9bf78e5a35a226d78
Autor:
Kier Om, Dominic Paquin-Proulx, Maria Montero, Kristina Peachman, Xiaoying Shen, Lindsay Wieczorek, Zoltan Beck, Joshua A Weiner, Dohoon Kim, Yifan Li, Thembi Mdluli, Zhanna Shubin, Christopher Bryant, Vishakha Sharma, Andrey Tokarev, Peter Dawson, Yohann White, Oliver Appelbe, Nichole R Klatt, Sodsai Tovanabutra, Jacob D Estes, Gary R Matyas, Guido Ferrari, Carl R Alving, Georgia D Tomaras, Margaret E Ackerman, Nelson L Michael, Merlin L Robb, Victoria Polonis, Morgane Rolland, Michael A Eller, Mangala Rao, Diane L Bolton
Publikováno v:
PLoS Pathogens, Vol 16, Iss 9, p e1008764 (2020)
To augment HIV-1 pox-protein vaccine immunogenicity using a next generation adjuvant, a prime-boost strategy of recombinant modified vaccinia virus Ankara and multimeric Env gp145 was evaluated in macaques with either aluminum (alum) or a novel lipos
Externí odkaz:
https://doaj.org/article/7a6c977bbc934d51bd9ae6ad3d6245bd
Autor:
Donn J Colby, Michael A. Eller, Dan H. Barouch, Pornsuk V. Grandin, Carla Truyers, Rasmi Thomas, Hanneke Schuitemaker, Eugene Kroon, Alexandra Schuetz, Joseph P. Nkolola, Amélie Pagliuzza, Frank Tomaka, Johan Vingerhoets, Hongshuo Song, Daniel J. Stieh, Sodsai Tovanabutra, Suteeraporn Pinyakorn, Michal Sarnecki, Nittaya Phanuphak, Mark de Souza, Carlo Sacdalan, Jintana Intasan, Somporn Tipsuk, Nicolas Chomont, Lindsay Wieczorek, Dominic Paquin-Proulx, Jintanat Ananworanich, Maria G. Pau, Nelson L. Michael, Lauren Peter, Victoria R. Polonis, Dohoon Kim, Merlin L. Robb, Zhanna Shubin
Publikováno v:
Nature medicine, 26(4), 498-501. Nature Publishing Group
We administered Ad26, modified vaccinia Ankara vectors containing mosaic HIV-1 antigens or placebo in 26 individuals who initiated antiretroviral therapy during acute human immunodeficiency virus infection as an exploratory study to determine the saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8c800af7823c94fc9f4cfb270ce182
https://pure.amc.nl/en/publications/safety-and-immunogenicity-of-ad26-and-mva-vaccines-in-acutely-treated-hiv-and-effect-on-viral-rebound-after-antiretroviral-therapy-interruption(3c9da660-f1cc-4e2d-bf62-3669f65f8441).html
https://pure.amc.nl/en/publications/safety-and-immunogenicity-of-ad26-and-mva-vaccines-in-acutely-treated-hiv-and-effect-on-viral-rebound-after-antiretroviral-therapy-interruption(3c9da660-f1cc-4e2d-bf62-3669f65f8441).html
Autor:
Melanie Merbah, Vincent Dussupt, Bonnie M. Slike, Kayvon Modjarrad, Suzanne Wollen-Roberts, Zhanna Shubin, Nelson L. Michael, Letzibeth Mendez-Rivera, Morgane Rolland, Shelly J. Krebs, Hongjun Bai, Yifan Li
Publikováno v:
Journal of Immunological Methods. 487:112874
Genus Flavivirus, which includes 53 virus species, is the leading cause of arthropod-borne diseases in humans. Diagnosis of these viral diseases is complicated by their overlapping epidemiology and clinical manifestations, and the fact that cross-rea
Publikováno v:
Immunogenetics. 70(3)
Rhesus macaque is an important animal model for studies testing interventions like antibody therapeutics; as such knowledge of inter-individual variations in function of genes affecting antibody recycling is important for optimal experimental design.
Autor:
C. David Pauza, Xiaoping Zhu, David C. Montefiori, Weizhong Li, Celia C. LaBranche, Zhanna Shubin, Guido Ferrari, Bhawna Poonia
Publikováno v:
Clinical and vaccine immunology : CVI. 24(6)
A goal for HIV prevention programs is to develop safe, effective vaccines that elicit durable and broadly protective antibodies. Many vaccine programs focus on the immune responses to critical epitopes in the gp120 portion of HIV envelope glycoprotei
Autor:
Celia C. LaBranche, Zhanna Shubin, Xiaoping Zhu, David Pauza, David C. Montefiori, Weizhong Li
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 74:76